Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
J Interferon Cytokine Res ; 19(5): 479-85, 1999 May.
Article in English | MEDLINE | ID: mdl-10386860

ABSTRACT

Verotoxin type 2 (VT2) produced by enterohemorrhagic Escherichia coli (EHEC) has been shown to have high cytotoxic potency toward several human B lymphoid cell lines with and without Epstein-Barr virus (EBV). Cell death, apoptosis induced by VT2, is closely correlated with the expression of receptor molecule Gb3/CD77, recognized by the toxin, but not with the infection or presence of EBV. Pretreatment of cells with interferon-alpha (IFN-alpha) for 24 h resulted in augmentation of apoptosis by VT2. Pretreatment within 8 h, however, was not effective. It has been reported that IFN-alpha-induced apoptosis is correlated with the induction of the 2',5'-OAS/RNase L system or dsRNA-activated protein kinase (PKR) or both. We have established persistent infection in both Akata and P3HR-1 cells with mumps virus. The persistently infected cell lines, P3HR-MP2 and Akata-MP2, showed poor induction of 2',5'-OAS and PKR in response to IFN-alpha. Augmentation of VT2-induced apoptosis by IFN-alpha was not found in the cell lines P3HR-MP2 and Akata-MP2. Therefore, these findings were interpreted to indicate that augmentation of VT2-induced apoptosis by IFN-alpha may be mediated by PKR and the 2',5'-OAS/RNaseL system. It is also suggested that mumps virus can suppress apoptosis and establish persistent infection.


Subject(s)
Antiviral Agents/therapeutic use , Bacterial Toxins/toxicity , Cytotoxins/toxicity , Escherichia coli , Interferon-alpha/therapeutic use , Mumps virus , Mumps/drug therapy , Apoptosis/drug effects , B-Lymphocytes/drug effects , Chronic Disease , Drug Synergism , Genome, Viral , Herpesvirus 4, Human/genetics , Humans , Shiga Toxin 2 , Signal Transduction/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...